David Brennan - Articles and news items

David Brennan, CEO, AstraZeneca

AstraZeneca reports terms of David Brennan’s retirement

Industry news, News / 16 July 2012 / AstraZeneca

AstraZeneca reported on the remuneration arrangements relating to David Brennan’s retirement…


AstraZeneca needs new strategy after boardroom shake up – EP Vantage investigates

Industry news, News / 27 April 2012 / AstraZeneca

As AstraZeneca PLC Chief Executive David Brennan steps down…

David Brennan, CEO, AstraZeneca

David Brennan to retire as AstraZeneca’s Chief Executive Officer

Industry news, News / 26 April 2012 / AstraZeneca

AstraZeneca announced that Chief Executive Officer and Board member, David Brennan has decided to retire…

Amgen logo

Amgen and AstraZeneca announce collaboration

Industry news, News / 2 April 2012 / Amgen

Collaboration comprises five monoclonal antibodies brodalumab (AMG 827) Phase 3 trial planned in 2012…


AstraZeneca to cut a further 7,300 jobs

Industry news, News / 2 February 2012 / AstraZeneca

AstraZeneca has announced new restructuring initiatives designed to improve productivity and strengthen the company’s capabilities…


Groundbreaking scientific collaboration gives UK academia access to compounds to advance medical research

Industry news, News / 5 December 2011 / AstraZeneca

A wide range of compounds will be made available FOC to UK medical researchers…


FDA approves new medicine BRILINTA (ticagrelor) for use in the US

Industry news, News / 20 July 2011 / AstraZeneca

The US FDA has approved BRILINTA (ticagrelor) tablets…


AstraZeneca to sell AstraTech to DENTSPLY International

Industry news, News / 22 June 2011 / AstraZeneca

AstraZeneca has agreed to sell its Astra Tech business to DENTSPLY for approximately $1.8 billion in cash…


AstraZeneca extends its investment in Russia with new predictive science centre in St Petersburg

Industry news, News / 16 June 2011 / AstraZeneca

AstraZeneca plans to establish a Predictive Science Centre in St. Petersburg…

European Commission Approves Brilique™ (Ticagrelor Tablets)

Industry news, News / 6 December 2010 / AstraZeneca

AstraZeneca announced today that the European Commission has granted marketing authorisation to BRILIQUE™ (ticagrelor tablets)…

CRESTOR Patent Upheld By US Court

Industry news, News / 30 June 2010 / AstraZeneca

AstraZeneca announced today that Judge Joseph Farnan, Jr., US District Court, District of Delaware, has found that the substance patent protecting CRESTOR (RE37,314 – the ‘314 patent) is valid and enforceable…

AstraZeneca and MMV Join Efforts in the Fight Against Malaria

Industry news, News / 28 June 2010 / AstraZeneca

AstraZeneca and Medicines for Malaria Venture (MMV) today announced a collaborative agreement designed to identify novel candidate drugs for the treatment of malaria…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...